This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sigilon Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Owen O'Connor: Innovator in Fabry Disease Treatment
Introduction
Owen O'Connor is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of medical treatments. His work primarily focuses on addressing rare diseases, particularly Fabry disease, through innovative compositions and methods.
Latest Patents
O'Connor holds a patent titled "Compositions, Devices, and Methods for Treating Fabry Disease." This patent represents his commitment to developing effective solutions for patients suffering from this genetic disorder. He has 1 patent to his name, showcasing his innovative approach to medical science.
Career Highlights
Owen O'Connor is currently employed at Sigilon Therapeutics, Inc., where he continues to advance his research and development efforts. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking therapies.
Collaborations
Throughout his career, O'Connor has worked alongside talented individuals such as Jared A. Sewell and David Peritt. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in the treatment of rare diseases.
Conclusion
Owen O'Connor's work in the treatment of Fabry disease exemplifies the impact of innovative thinking in the medical field. His contributions through patents and collaborations highlight the importance of research in developing effective therapies for patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile